Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA weighs risks of approving Singulair as over-the-counter allergy medication
FDA weighs risks of approving Singulair as over-the-counter allergy medication
FDA weighs risks of approving Singulair as over-the-counter allergy medication
Submitted by
admin
on April 30, 2014 - 10:22am
Source:
Yahoo/AP
News Tags:
Singulair
FDA
OTC
Merck
Headline:
FDA weighs risks of approving Singulair as over-the-counter allergy medication
Do Not Allow Advertisers to Use My Personal information
